DONG SUNG BIO PHARM.CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,240 KRW | +0.38% |
|
+1.35% | -9.03% |
| 2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
| 2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
| Sales 2012 | 84.46B 62.34M 5.2B | Sales 2013 * | - | Capitalization | 120B 88.43M 7.37B |
|---|---|---|---|---|---|
| Net income 2012 * | - | Net income 2013 * | - | EV / Sales 2012 | 0.8 x |
| Net cash position 2012 * | - 0 0 | Net cash position 2013 * | - 0 0 | EV / Sales 2013 * | - |
| P/E ratio 2012 * |
-
| P/E ratio 2013 * |
-
| Employees | 290 |
| Yield 2012 * |
-
| Yield 2013 * |
-
| Free-Float | 66.36% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.38% | ||
| 1 week | +1.35% | ||
| Current month | +0.96% | ||
| 1 month | -4.73% | ||
| 3 months | -4.73% | ||
| 6 months | -24.06% | ||
| Current year | -9.03% |
1 week
5 120.00
5 320.00
1 month
5 020.005 620.00
Current year
5 020.006 280.00
1 year
5 020.007 990.00
3 years
5 020.0012 200.00
5 years
5 020.0027 550.00
10 years
3 190.0049 300.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Chan-Tae Ko
AUD | Comptroller/Controller/Auditor | 65 | - |
Bong-Rim Cho
PRN | Corporate Officer/Principal | 62 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yang-Gu Lee
CEO | Chief Executive Officer | 62 | - |
Young-Ryul Lee
BRD | Director/Board Member | 66 | 29/19/29 |
Won-Gyoon Na
BRD | Director/Board Member | 38 | 28/22/28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 7 M€ | +0.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 5,240 | +0.38% | 24,642 |
| 02/24/02 | 5,220 | +0.58% | 78,682 |
| 30/24/30 | 5,190 | +0.39% | 23,060 |
| 29/24/29 | 5,170 | 0.00% | 33,415 |
| 26/24/26 | 5,170 | -1.34% | 67,302 |
End-of-day quote Korea S.E., May 03, 2024
More quotes
Dongsung Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include anti-rheumatic, anti-inflammatory analgesics, anti-inflammatory enzymes, drugs for cardiovascular system, gastrointestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antibiotics, antidiarrheals, antifungals, oral hypoglycemic agents, hormones, hypnotics and others. It also produces hair dyes and cosmetics. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.03% | 88.44M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +14.32% | 13.79B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
- Stock Market
- Equities
- A002210 Stock
